Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Holding TSE:CRDL?
Track your performance easily

Cardiol Therapeutics (CRDL) Financial Statements

143 Followers

Cardiol Therapeutics Financial Overview

Cardiol Therapeutics's market cap is currently ―. The company's EPS TTM is C$-0.441; its P/E ratio is -6.19; Cardiol Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is C$-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -7.64MC$ -5.93MC$ -7.47MC$ -7.09MC$ -10.68M
EBITDAC$ -7.57MC$ -5.87MC$ -7.41MC$ -7.03MC$ -10.68M
Net Income Common StockholdersC$ -7.64MC$ -5.93MC$ -7.47MC$ -7.09MC$ -10.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 34.93MC$ 40.54MC$ 44.94MC$ 49.47MC$ 59.47M
Total AssetsC$ 36.70MC$ 43.05MC$ 47.17MC$ 52.69MC$ 62.03M
Total DebtC$ 174.34KC$ 181.21KC$ 48.19KC$ 60.66KC$ 72.87K
Net DebtC$ -34.76MC$ -40.36MC$ -44.89MC$ -49.41MC$ -59.40M
Total LiabilitiesC$ 8.45MC$ 8.18MC$ 8.42MC$ 7.13MC$ 9.83M
Stockholders EquityC$ 28.25MC$ 34.87MC$ 38.75MC$ 45.56MC$ 52.20M
Cash Flow-
Free Cash Flow----C$ -8.97M
Operating Cash FlowC$ -6.46MC$ -3.41MC$ -5.35MC$ -9.95MC$ -8.92M
Investing Cash FlowC$ -10.71KC$ -5.58KC$ -3.89KC$ -44.14KC$ -47.83K
Financing Cash FlowC$ -13.84KC$ -13.84KC$ -13.84KC$ -13.84KC$ -13.84K
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Cardiol Therapeutics Debt to Assets

Cardiol Therapeutics Cash Flow

Cardiol Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis